ArticleMedComm2024

CREB3 suppresses hepatocellular carcinoma progression by depressing AKT signaling through competitively binding with insulin receptor and transcriptionally activating RNA-binding motif protein 38.

Yi He et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.